TOP-139 Combination of liver steatosis and premenopausal is a risk factor for DILI due to cyclin-dependent kinase 4/6 inhibitors as first-line treatment for metastatic breast cancer

Autor: Vega-Cano, Kreina Sharela, Ruiz-Ortega, Lourdes, Baselga, Pau Mascaró, Esteban, Paula, Viñas, Oriol Mirallas, Filippi-Arriaga, Francesca, Ramentol, Laia Joval, Ruiz-Cobo, Juan Carlos, Buch, Pau Benito, Yaringaño, Jesus, Molina, Gaspar Joaquin, Puerto, Diego Gomez, Gómez, Lucia Sanz, Adelantado, Esther Zamora, Buti, Maria, Ezquerra, Meritxell Bellet, Barciela, Mar Riveiro
Zdroj: In Journal of Hepatology June 2024 80 Supplement 1:S702-S702
Databáze: ScienceDirect
Externí odkaz: